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CHAPTER 1: INTRODUCTION 
 
I. MICROARRAY 
Living organisms are composed of complex gene structures that are hard to assign 
biological functions to. Even more challenging is attempting to understand their 
fundamental networking inside living cells. This raises the million dollar question. 
Scientists are interested in finding the various pathways and directions needed to solve 
the problems that are revealed. A molecular biology field called functional genomics (FG) 
was developed by biologists to study the behavior of complicated gene structures. FG 
represents genome analysis and more specifically a study of gene function through 
different high technology experiments [1]. FG involves the study of at least three areas: 
transcriptomics, proteomics, and metabolomics [2]. One of the popular experimental 
techniques used to study transcriptional genetic responses in this field is the microarray 
experiment technique [3-4]. The microarray experiment technique was first developed as 
a two-channel technology [3, 5] and is now widely used to explore and study the genome.  
The Deoxyribonucleic acid (DNA) microarray typically involves hybridization of 
two messenger ribonucleic acid (mRNA) samples, in which they are converted into a 
cDNA sample. It is used primarily to study the difference in expression levels between 
two mRNA samples. Microarray data contains a wealth of information about thousands 
of genes that are hidden behind high noise levels and low signal levels. Thus, the main 
goal in this area is to explore and understand the biological behaviors and functions of 
these genes that play an important role in creating living organisms. 
A good statistical method is always preferred to efficiently explore and extract the 
information hidden behind high noise levels and low signal levels. There are various 
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statistical methods proposed to analyze microarray data, yet scientists and statisticians are 
still collaborating to develop a more powerful method that is able to effectively and 
efficiently analyze high noise level microarray data. Several popular statistical methods 
that are widely used to analyze high dimensionality microarray data in the field today are 
principal component analysis (PCA) [2, 6-7], the simple linear model or mixed-effects 
linear model [4, 8], Student’s t-test controlling for false discovery rate (FDR) based on p 
value [9-12], network component analysis (NCA) [13- 15], and the Wilcoxon Mann-
Whitney [13, 16] and Bayesian method [17-19]. 
II. PRINCIPAL COMPONENT ANALYSIS 
Principal component analysis (PCA) is a powerful statistical method used to 
analyze multivariate and large dimensionality data in a reduced dimensionality. PCA uses 
mathematical formulas and procedures to orthogonally transform the original data to a 
new coordinate data system that is represented by principal components (PCs) [20]. PCs 
are the linear combinations of eigenvectors and the variables. The PCA approach uses the 
covariance matrix (scaled sum of squares and cross products) or correlation matrix (sums 
of squares and cross products from standardized data) to generate the PCs. The PCA 
approach will rank the largest eigenvalue (i.e. maximum variance) as the first principal 
component (PC 1) and the smallest eigenvalue as the last PC. These PCs represent the 
contribution of each gene to the data and thus they are used in data analysis as weight 
factors. The main concern of PCA is explaining the variance-covariance structure of a set 
of variables through linear combinations of the variables [20]. 
PCA is a non-parametric analysis and the answers are not based on any 
hypothesis or probability distribution. The only assumption that PCA has is that all the 
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data are a linear combination of certain basis vectors [21]. Most statistical methods tend 
to eliminate partial important information and thus convey a misleading message. PCA, 
however, does not possess this problem because it is able to maximize the variability of 
data while minimizing the dimensionality of the data set. 
III. MOTIVATION AND THESIS ORGANIZATION 
Rollins et. al. (2006) proposed a novel PCA-based method to analyze microarray 
data and identify assay specific gene signatures in functional genomic studies. The 
proposed PCA-based method used PCA in two ways to explore the data: Eigengene (EG) 
where the genes are treated as variables and Eigenassay (EA) where the assays are treated 
as variables. This method is unique because it is the only method that uses gene 
contribution (product of loading and gene expression level) to create rank ordered assay 
specific gene signatures.  
Overall, this method performed very well in analyzing microarray data and in 
identifying gene(s) that are important to a particular physiological condition of interest. 
But one limitation of this method is its ability to produce a good differentially expressed 
gene signature that expressed the differences between two assay groups. We are looking 
to improve the assay-specific gene signature produced from this method so that we can 
obtain a signature that looks like an “L-shape” to indicate the top genes that are really 
showing the differences while the rest of the genes show zero differences.   
Hence, with these ideas in mind, we have extended the work of Rollins et al. 
(2006) and developed a method that can improve the performance of the PCA-based 
method in identifying assay-specific and differentially expressed gene signatures in 
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functional genomic studies. This research not only improved the PCA-based method 
proposed by Rollins et. al.(2006) but also developed two new test statistics that are able 
to identify differentially expressed gene signatures. More specifically, this work proposed 
two new PCA-based test statistics that have high statistical power and low false discovery 
rate. 
To this end, this thesis is organized as follows: Chapter 2 gives brief reviews on 
various statistical methods that are adopted for mining of microarray data. Chapter 3 
provides the ideas and details on the two new test statistics developed. Chapter 4 gives an 
illustration of applying the proposed method to a real data set followed by results and 
discussion. Last but not least, Chapter 5 gives general conclusions about the work of this 
research and also suggests a few ideas for future research. 
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CHAPTER 2: LITERATURES REVIEW 
 This chapter will discuss a few common statistical methods applied by the 
scientists to perform microarray data analysis and interpretation. This chapter is broken 
down into several sections to briefly describe and discuss some general statistical 
methods such as PCA, the simple linear model or mixed effect model, the Student’s t-test 
controlling for FDR, the Bayesian method, and network component analysis (NCA). 
There are a lot more statistical methods packages that are available for microarray data 
analysis but for the purpose of this thesis, I will only discuss a few methods that I 
overviewed.  
I. PRINCIPAL COMPONENT ANALYSIS 
Rollins et. al(2006) used the PCA-based method to analyze large dimensionality 
microarray data to identify assay-specific gene signatures in functional genomics studies. 
This method creatively used gene contribution, which is a product of the linear 
combination of the loading and gene expression level to obtain the desired signatures. 
Their method also employed the PCA approach in two different methods. The first 
method treated genes as variables and was called the Eigengene (EG) method, while the 
second method treated assays as the variables and was called the Eigenassay (EA) 
method. This method was proven to successfully identify assay-specific gene signatures 
for functional genomics studies.     
Liu et. al. (2002) proposed block PCA to analyze microarray data. The uniqueness 
of this method is that PCA was applied to the principal components instead of the 
original variables [2]. The variables or genes in the original data were first grouped into 
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several blocks based on their similarity in behavior and functionality. The PCA was then 
performed on each block to obtain a small number of variance-dominating PCs. These 
PCs were then combined together to form a data set and PCA was performed on this 
“data” again. They showed that block PCA was an effective method to identify genes that 
showed insight into cancer phenotypes in their studies.   
A PCA based approach is widely applied because this method does not assume a 
distribution for the data and the only assumption it has is that all the data can be 
represented as a linear combination of certain basis vectors [3]. The PCA approach also 
provides researchers with the percentage of variation accounted for by the data by 
choosing a particular PC [4]. 
II. LINEAR MODEL, MIXED EFFECT MODEL, STUDENT’S T- TEST 
The second method described here is the simple linear model and the mixed effect 
model incorporating the Student’s t test when a study is looking to identify genes that 
expressed differentially from other genes across two or more different conditions.  A t-
statistic is used by some researchers to test for significant differences expressed by a gene 
across two different conditions.  The main idea behind this method is to obtain a p-value 
for each of the genes involved and then make a decision with the help of test statistics 
and the p-value. Ge et. al. (2009) used Welch T-statistics, which are an adaptation from 
the Student’s t-test, to perform the data analysis and control the false discovery rate 
(FDR).  
In this particular study, the p-value typically corresponds to a null hypothesis 
stating that the genes are not differentially expressed across two or more assay groups. 
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Since the p-value is often misunderstood to be the probability that the null hypothesis is 
correct, most researchers believe that a large p-value corresponds to a gene that is not 
differentially expressed from the other across two conditions. Even though this allows for 
straight forward decision making, the interpretation of the p-value is not correct because 
p-value is computed under the assumption that the null hypothesis is true.      
Storey and Tibshirani (2003) have converted the p-value to the q-value to control 
for false discovery rate (FDR) [6]. Let me describe a simple example that will help to 
illustrate the meaning of the FDR.  For example, let 200 genes, identified to be 
differentially expressed compared to all other genes, have a 5% FDR. Then there is a 
chance that 10 out of the 200 genes are not really differentially expressed as claimed. The 
q-value on the other hand can control the FDR easily because the q-value is inversely 
related to the p-value. Thus, if a researcher wishes to have a 5% FDR, he or she can 
declare all genes with a q-value less than 0.05 to be differentially expressed. Hence, 
controlling the gene signature using the FDR is a very popular approach since it can help 
to minimize the false positive rate. 
III. NETWORK COMPONENT ANALYSIS (NCA) 
The next method that I would like to describe here is the network component 
analysis (NCA) method. This method was first proposed by Liao et. al. (2003) after 
validating this method experimentally through spectra absorbance of network 
components for various hemoglobin species [7]. This method has the ability to uncover 
the hidden regulatory signals from the output of network systems [7]. This method 
decomposes the data set into two matrices, where the first matrix consists of regulatory 
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signals and the second matrix encodes the connectivity strengths between the regulatory 
layer and the output signals. The advantage of this method is its ability to properly handle 
the prior knowledge of a structure characterizing a given system without making any 
assumptions on the statistical properties.  
Liao et. al. (2003) applied this method to microarray data generated from the 
yeast Saccharamyces cerevisiae and the activity of various transcription factors during 
the cell cycle. Using the NCA method, they successfully generated a network consistent 
representation of the regulatory signals [7]. Tran et. al. (2005) have further extended the 
NCA method to the generalized NCA (gNCA) method. gNCA incorporates the regulatory 
signal constraints arising from genetic knockouts [8]. The gNCA method was applied on 
a microarray data set to study the effect of transcription factor activities for an E. coli 
regulator (arcA) deletion mutant during the glucose acetate transition [8]. Incorporating 
both network structure constraints and signal constraints imposed by genetic knockouts, 
gNCA was able to identify transcription factors that expressed differently between wild 
type strain and mutant strain.    
IV. OTHER METHODS 
Besides the three statistical methods described above, there are many more 
statistical methods that are being used to analyze microarray data with high 
dimensionality. Some researchers have selected the Bayesian approach for data analysis 
because this method is able to effectively analyze the data while reducing the 
dimensionality of the original data set [9-10]. Efron et. al. (2001) and Kendsiorski et. al. 
(2003) used the empirical Bayesian method to analyze their microarray data. The 
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Empirical Bayesian method is similar to the regular Bayesian method.  The only 
difference is that the prior distribution is not independent of the data as in the typical 
Bayesian method. For the empirical Bayesian method, the prior distribution is estimated 
from the data itself.  
Non-parametric models such as the Wilcoxon Mann-Whitney [12] and Wilcoxon 
Signed Rank [13] tests are favored when the data are not normally distributed or cannot 
be assumed to have a normal distribution. The Wilcoxon Mann-Whitney test, sometimes 
called the Wilcoxon rank-sum test, is used when two samples are independent of each 
other, while the Wilcoxon signed rank test is applied when two samples are related or a 
repeated sample is taken on the same sample. 
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CHAPTER 3: AN EXTENDED DATA MINING METHOD FOR 
IDENTIFYING DIFFERENTIALLY EXPRESSED ASSAY-SPECIFIC 
SIGNATURES IN FUNCTIONAL GENOMIC STUDIES 
A paper to be submitted to BMC Bioinformatics 
Derrick K Rollins, AiLing Teh, and Dan Nettleton
 
ABSTARCT 
Background: Microarray data sets provide relative expression levels for thousands of 
genes for a small number, in comparison, of different experimental conditions called 
assays. Data mining techniques are used to extract specific information of genes as they 
relate to the assays. The multivariate statistical technique of principal component analysis 
(PCA) has proven useful in providing effective data mining methods. This article extends 
the PCA approach of Rollins et al. (2006) to the development of ranking genes of 
microarray data sets that express most differently between two biologically different 
grouping of assays. This method is evaluated on real and simulated data and compared to 
a current approach on the basis of false discovery rate (FDR) and statistical power (SP) 
which is the ability to correctly identify important genes. 
Results: This work developed and evaluated two new test statistics based on PCA and 
compared them to a popular method that is not PCA based. Both test statistics were found 
to be effective as evaluated in three case studies: (i) exposing E. coli cells to two different 
ethanol levels; (ii) application of myostatin to two groups of mice; and (iii) a simulated 
data study derived from the properties of (ii). The proposed method (PM) effectively 
identified critical genes in these studies based on comparison with the current method 
(CM). The simulation study supports higher identification accuracy for PM over CM for 
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both proposed test statistics when the gene variance is constant and for one of the test 
statistics when the gene variance is non-constant. 
Conclusions: PM compares quite favorably to CM in terms of lower FDR and much 
higher SP. Thus, PM can be quite effective in producing accurate signatures from large 
microarray data sets for differential expression between assays groups identified in a 
preliminary step of the PCA procedure and is, therefore, recommended for use in these 
applications. 
I. INTRODUCTION 
It is well known that living organisms have complicated gene structures. However, 
while major advancements have been made in recent years, understanding of the 
biological functions of each individual gene is still quite limited. Active research is 
strongly focused on understanding the behavior of genes and as well as the highly 
complex metabolism and regulatory network inside living cells [1]. This effort falls under 
a molecular biological field called functional genomics (FG). There are at least three 
areas in which experimental techniques are widely applied in FG: transcriptomics, 
proteomics, and metabolomics [2]. A combination of leading scientific techniques as well 
as powerful mathematical and statistical tools for data analysis makes the task of 
identifying important transcriptome, proteome, and metabolome corresponding to a 
biological effect promising. Typical studies in these areas involve the identification of 
possible behavior and responses of species under various genetic backgrounds as well as 
environmental factors (i.e. assay).  
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There are different high technology techniques applied in FG field to advance 
understanding of the transcriptional genetic response of many organisms in various 
environmental perturbations [1]. One of the techniques that have been adopted in this 
field is a multiplex technology called DNA microarray [3]. A new technique that is 
becoming popular and will probably displace array-based measurement in FG is next-
generation sequencing (RNAseq) [4-5]. These techniques have the ability to generate data 
sets that consist of expression levels of thousands of genes, providing a wealth of 
information that is hidden by high noise levels, low signal levels, and a relatively small 
number of experimental units to the number of genes studied. More specifically, since the 
data set containing the gene expression measurements consists of a lot more genes than 
assays, analytical techniques are needed to provide accurate gene identification under a 
large number of gene candidates that is much greater than the number of experimental 
runs.  
To achieve this objective, traditional statistical methods, such as principal 
component analysis (PCA) [2, 3-8], the focus of this article, are being retrofitted to 
provide effective statistical inference in this challenging context of microarray data 
analysis. Other methods included linear model analysis [9-14], Bayesian method [17 - 19] 
and neural network analysis (NCA) [18-20].  Thus, statistics is playing a critical role 
through the development of methodologies that give high statistical power (SP) (i.e., 
accurate identification), and low false discovery rate (FDR) [21] (i.e. low 
misidentification). To this end, this article introduces two new PCA based statistics for 
determining gene rank for differential expression between two PCA identified assay 
groups. This work extends the technique introduced by Rollins et al. (2006) that 
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determines gene rank for a single PCA identified assay group. Thus, the proposed method 
(PM) in this work is aimed at finding the genes with high expression levels in one group 
and low expression levels in the other group.  
The PM method uses PCA to first establish the existence of the assay groupings 
of interest. Then using the results that established the grouping, the differential 
contribution for each gene is determined using a statistic based on eigenvalues. This 
article proposes and evaluates two statistics. The first one is the group averaged 
difference of eigenvalue linear combinations that we call Tdiff.  The second one divides 
Tdiff by its estimated pooled standard deviation that we call Tscaled. The genes are ranked 
based on the largest absolute value of these statistics. The PM is evaluated against the 
ranking determined by the well known Student’s t-statistic [14] that we call Tpooled in this 
work. We will refer to Tpooled as the current method (CM) which is actually a subclass of 
the PM that weighs each assay equally in each group. Note that for the CM the assay 
members in each group is not established based on the data but by á priori considerations. 
In contrast, for the PM the data drives the assay weight as well as group assignment of 
the assays. 
The CM and PM are applied in the following three case studies to compare their 
effectiveness (i.e., power) in identifying assay-specific signature: (i) exposure of E. coli 
cells to two different levels of ethanol concentration [2]; (ii) the use of myostatin as 
inhibitor of skeletal muscle growth for five 5-weeks-old myostatin and non-treated mice 
[9]; and (iii) a simulation study based on statistical properties of the second case study.  
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This work is organized into the following section. The Background Section gives 
a brief review of PCA and connects it to our application in FG’s data analysis. This 
section is followed by the Methods Section that derives and presents the test statistics of 
the CM and PM. These test statistics are evaluated and compared in three studies in the 
Results and Discussion Section. The final section summarizes the results and gives 
concluding remarks on the contribution of this work.  
II. BACKGROUND 
The microarray data set is given as an m by n matrix X where n is the number of 
assays expressed along columns (i.e. variables) and m represents the number of genes 
expressed along rows. The cells in this matrix are given as xij which is the expression 
level of the i
th
 gene for the jth assay (i.e. condition). Principal component analysis (PCA) 
is a multivariate technique that mathematically transforms (rotates) the original 
coordinate system to a new orthogonal coordinate system based on correlations among 
the variables [20]. The principal components (PCs) are eigenvectors generated from 
either the covariance matrix (scaled sum of squares and cross products) or the correlation 
matrix (sums of squares and cross products from standardized data) of the variables 
involved. They are used to construct n linear combinations of the n variables that can be 
thought of as n pseudo variables [20]. A PC is rank ordered by the amount of variation in 
the original data set that it captures.  
 An illustration is given in Fig. 1 that shows a visual representation of a two-
dimensional data system (x) and a rotated data system (z). As shown, the new coordinated 
system points z1 in the direction with the greatest spread in the data. The other variable, z2, 
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points in a direction that is orthogonal to z1, but also seeks to maximize spread in this 
direction. The first PC determines z1 and the second PC determines z2. A data matrix of 
rank n will give n PCs that are linear combinations of the variables in the original data 
matrix that can be described as n pseudo variables. The goal in this application of PCA is 
to obtain at least one pseudo variables that represent the biological behavior of interest. 
This can be a PC that represents a small portion of the total variation making it a 
potentially very powerful data mining approach. 
 
Figure 1. Visual representation of original data system and the rotating data system.  
The figure represented the original data system on the horizontal and vertical axis while 
the new rotating data system is represented as z1 and z2. Variance-covariance matrices for 
original data system and rotating data system are showed on the right of the figure.  
 
 The top of Fig. 2 shows the relationship between the original data matrix, X, the n 
by n PC loading matrix, L, and the m by n pseudo data matrix, called the scores matrix, S. 
The PCs derived from X are called eigengenes (EG) because the elements of S represent 
pseudo values for gene expression. In Fig. 2 the bottom set of matrices are derived from 
the transpose of X which is an n by m matrix. In this case the loading matrix is m by n in 
19 
 
dimension and the scores matrix is n by n in dimension. The PCs derived from the 
transpose of X are called eigenassays (EA) because the elements of the scores matrix 
represent pseudo assays. The proposed method (PM), following Rollins et al. (2006), uses 
both EG and EA approaches to develop signatures sets of ranked genes. In the next 
section we derive the EG and EA statistics for determining gene contribution for the PM.
 
Figure 2. Visual representation of data, loading, and score matrices for X and X
T 
The top matrices are for X and determining EGs and the bottom ones for X
T
 and for 
determining EAs. 
 
III. METHODS 
(a) Eigengene Contribution Approach 
 The first step in the eigengene (EG) approach of the PM is to standardize the 
elements of X to give the standardized matrix Z with each element equal to
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 z x x sij ij j j  / , where x j and s j are the sample mean and sample standard deviation of 
the data in column j, respectively. The following distributional assumptions apply: 
 x Nij
indep
x xj i~ , , 
2
   z Nij
indep
z zj i~ , , 
2
  x N mj
indep
x jj~ , / , 
2
and E[ s j
2 ] =  j j
2  .  These 
assumptions indicate that each assay can have it own mean expression level, 
 x j j n 1, , ,  and that the variance of each gene is constant across assays but can be 
different for different genes. Also, z j i j 0 ,  since E[xij] = E[ x j ] = x j i j  , .  
These 
assumptions will be utilized later after proposing the test statistics. 
 The elements of the EG scores matrix, S
EG
, are determined by  
s z z z z
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where sij
EG is the score for the i
th
 gene using the j
th
 vector of EG loadings,  ij
EG is the i
th
 
loading for the  j
th
 EG vector, and gijk
EG is the contribution for the i
th
 gene, on the k
th
 assay 
from the j
th
 EG loading vector. Let A = Group A with nA assay members and B = Group 
B with nB assay members with no members in common with Group A such that  
2   n n nA B                                                      (2) 
The mean contribution for i
th
 gene from the j
th
 EG loading vector for Groups A and B, 
respectively are 
g
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where k' and k'' are the assay members in Groups A and B, respectively. Finally, the EG 
differential gene contribution between Groups A and B for the i
th
 gene from the j
th
 EG 
loading vector is given as 
dg g gij
EG
ij
EG
ij
EGA B                                              (5) 
The basic difference between the method in Rollins et al. (2006) and this extension is that 
work developed gene signatures for individual group using equations of the form given 
by (3) and (4) and this work uses equation of the form given by Eq. 5.  
(b) Eigenassay Contribution Approach 
 As stated above, the EA approach uses the transpose of X as the data matrix 
treating the genes as the variables. Following Rollins et al. (2006), X
T
 is not standardized 
in the EA approach as in the EG approach. The elements of scores matrix, S
EA
, are 
determined from Eq. 6 as follows: 
s x x x
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         (6) 
where sij
EA is the score for the i
th
 assay using the j
th
 vector of EA loadings,  ij
EA is the i
th
 
loading for the  j
th
 EA vector, and gijp
EA is the contribution for the p
th
 gene, on the i
th
 assay 
from the j
th
 EA loading vector. As above, for A = Group A with nA assay members and B 
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= Group B with nB assay members with no members in common with Group A, we obtain 
the contribution expressions as follows. The mean contribution for p
th
 gene from the j
th
 
EA loading vector for Groups A and B are 
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respectively, where i' and i'' represent the assay members in Groups A and B, 
respectively. Finally, the EA differential gene contribution between Groups A and B for 
the p
th
 gene from the j
th
 EG loading vector is given as 
dg g gjp
EA
jp
EA
jp
EAA B                                                 (9) 
(c) Test Statistics 
 The next step after deriving the gene contribution equations is to define the 
decision or test statistics based on these derivations. Tdiff for EG and EA are equivalent to 
Eqs. 5 and 9, respectively. More specifically, 
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The variances for the components of these equations are given below by treating the 
loadings as fixed variables: 
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Thus, combining Eqs. 10-11, the variances for EGdiffijT and 
EA
diff jp
T respectively are: 
         V T
n n n n
diff
EG z
A
k j
EG
over k
z
B
k j
EG
over k
z
A
k j
EG
over k B
k j
EG
over k
ij
i i
i
   





   
 

2
2
2
2
2
2
2
2
2
2
21 1
   '
'
''
''
'
'
''
''
  (16) 
  
       V T
n n n n
diff
EA
pj
EA xp
A
pj
EA xp
B
pj
EA
xp
A B
pj
   





  
2
2
2
2
2
2 1 1                  (17) 
The scale test statistic in the EG case can now be given by dividing Eq. 10 by the 
estimated standard deviation using Eq. 16: 
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and sB zi
2  are the sample variances for the standardized expression levels for Groups 
A and B, respectively, corresponding to the i
th
 gene. Note that when 
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this case where the variation of the assays are all similar, V(zij) is taken to equal 1 and  
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 Similarly, the scaled test statistic in the EA case can also be given now by 
dividing Eq. 11 by the estimated standard deviation using Eq. 17: 
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and sB xp
2
 are the sample variances for the un-standardized expression levels for 
Groups A and B, respectively, corresponding to the p
th
 gene. Note that Tscale
EA
JP
 is 
independent PCA loadings and thus, does not benefit from PCA. In actuality, Eq. 21 is 
the commonly known Student’s t-statistics [14]; thus, 
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JP,
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25 
 
From Eq. 23 it is clear that scaling the EA differential contribution is not providing any 
new technique in PCA and therefore is not a useful result under the PM. Thus, we do not 
propose scaling for the EA approach. 
  The steps for applying the PM are as follows: 
1. Standardize X to obtain Z. 
2. Obtain the loading and scores matrices for X (EG) based on correlation. 
3. Obtain the loading and scores matrices for X
T
 (EA) based on covariance. 
4. For each of the n EG loading vectors, plot its loadings against the assay 
number. Select the plot(s) that separate the assays into desired or interesting 
groups for further analysis. 
5. For each n EA score vectors, plot its scores against the assay number. 
Select the plot(s) that separate the assays into desired or interesting groups 
for further analysis. 
6. For each selected EG loading vector in Step 4, using Z and Eq. 5 determine 
the differential EG contribution for each gene.  
7. For each selected EA loading vector in Step 5, using X and Eq. 9 determine 
the differential EA contribution for each gene.  
8. For each case in Steps 6 and 7, rank order the differential contribution and 
then table (with the corresponding gene)and plot these values against the 
rank. These signature plots can be used to determine where to make cutoffs 
as described in Rollins et al. (2006). 
 In the next section we evaluate the proposed test statistics that we have derived  
in this section against a current method that uses the Student’s t-test statistic. This work 
also includes an evaluation to determine when it is better to choose Tdiff or Tscale.  
IV. RESULTS AND DISCUSSIONS 
 The best choice for a test statistics is the one that has the highest statistical power 
(SP) and the lowest false discovery rate (FDR) [21]. This section presents three case 
26 
 
studies to evaluate the proposed test statistics against one another and against a current 
method (CM) that uses Tpooled. The first study revisits the single group analysis in Rollins 
et al. (2006) involving exposure of E. coli cells to two different levels of ethanol 
concentration [2]. The second study applies the proposed method (PM) to data from 
Steelman et al. (2006) [9]. This data set involves the use of myostatin as an inhibitor of 
skeletal muscle growth for five 5-weeks-old myostatin (called “mutant”) and non-treated 
(called “wild-type”) mice in each group. The third study is a mathematically simulated 
data study using characteristics of the data from Study 2.  
Exposure of E. coli cells Study 
 The data set for the first case study contains E. coli cells that were exposed to two 
different ethanol concentrations. In Rollins et al. (2006) ranked signatures were obtained 
for non-ethanol (i.e., non-treated) (Group A) and ethanol (Group B) separately. Thus, 
these signatures ranked the genes based on their contribution to the score of their group.  
However, the goal of this work is to obtain a ranked signature of the genes that is based 
on the difference of gene contribution between the two groups. Therefore, under this 
objective, genes with high contribution in both groups would not be ranked high; whereas, 
genes with low contribution in one group and high contribution in the other group could 
be ranked high based on the greatest negative, positive, or absolute difference, depending 
on the interests of the experimenter. For this study, we ranked the genes based on 
absolute difference for evaluative purposes. 
 The results of this study using the PM are given in Table 1 and Fig. 3. These 
results were obtained from the first PC for an EA analysis using Tdiff
EA
i1
only to determine 
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differential gene contribution. This PC was selected, as supported by Fig. 3, because it 
separated the two groups in the score plot quite well. The plot on the right in Fig. 3 gives 
the differential contribution calculated from Tdiff
EA
i1
by rank with the rank decreasing with 
increasing value on the horizontal axis. As this figure shows, the top genes clearly 
standout by their distinct separation and how they line up almost vertically along the 
vertical axis. Table 1 gives the top 20 genes. This list contains some of the top genes in 
the ethanol and non-ethanol signatures in Rollins et al. (2006) as indicated. In addition, it 
contains genes that were not ranked very high in either signature. However, note that 
each gene is at opposite ends of the signatures in Rollins et al. (2006) in support of their 
differential significance. Thus, the PM has potentially found genes that might express 
relatively low within assays of similar conditions but quite differently between assays of 
different conditions. Follow up experiments would be necessary to verify these findings 
which is beyond the scope of this work. 
Skeletal Muscle Growth in Mice Study 
 The second study is a data set that involved the use of myostatin as inhibitor of 
skeletal muscle growth for five 5-week-old myostatin (called “mutant”) and non-treated 
(called “wild-type”) mice in each group. A powerful method for ranking genes and 
determining the size of signatures is the Q-method developed by Storey and Tibshirani 
(2003). The Q-method uses Tpooled and a novel method for achieving high SP and low 
FDR. The Q-method first uses Tpooled to obtain p-values then convert to q-values in order 
to determine where to cut-off signatures based on a maximum q-value. Given that the q-
value is related to the p-value, one could also rank genes based on p-values or their Tpooled 
values which are inversely related. Since we are primarily interested in ranking genes in 
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this work we will compare the techniques based on the abilities of Tpooled and the PM to 
find top ranked genes.  
Table 1: Top 20 genes that showed distinct difference between ethanol and non-
ethanol along with their ranking  
The "*" gives the rank in the ethanol and non-ethanol signature in Rollins et al. (2006). 
Rank 
Gene 
Name 
EtOH 
Rank* 
Non-
EtOH 
Rank* Rank 
Gene 
Name 
EtOH 
Rank* 
Non-
EtOH 
Rank* 
1 b2387 729 2001 11 argT 925 2330 
2 ybdO 558 2182 12 argH 2 4286 
3 b1455 959 2120 13 ycbE 317 3626 
4 gltD 2884 151 14 b0538 328 2658 
5 appY 360 2457 15 citB 372 2642 
6 caiA 5 3810 16 wbbH 2952 408 
7 b0960 2664 787 17 ccmD 2605 1083 
8 yaiD 1 4284 18 agaA 885 2483 
9 b1815 3178 43 19 ymcC 568 2587 
10 ydaK 375 2548 20 abc 389 2705 
 
 
 
 
 
si
EA
1               Tdiff
EA
p1
  
 
Figure 3. EA1 Score plot (a) and gene signature plot (b) for the E. coli in ethanol 
and non-ethanol study  
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The score plot shows excellent grouping for the non-ethanol (A) and ethanol (B) assays 
(B). For the signature plot on the right, the rank decreases as the number increases. The 
top ranking genes seen on the upper left in plot (b) show excellent ranking as evidenced 
by the vertical line and clear separation of the most highly ranked genes.  
 
PCA results for PM are given in Fig. 4.  These results were obtained from the first 
PC for an EA analysis using Tdiff
EA
i1
only to determine differential gene contribution. This 
PC was selected, as supported by Fig. 4, because it separated the two groups in the score 
plot quite well. As shown by the Tdiff
EA
i1
plot on the right, the top genes clearly standout by 
their distinct separation and by how they line up along the vertical axis. The top genes 
that the PM  identified were genes identified in Steelman et  al. (2006). In addition, it also 
identified genes that were not previously identified in their work.  
A comparison of the PM and the CM is given in Table 2. In this table, the top 200 
genes of the CM are selected as the base set. The number and percentage of the top 10, 
20, . . .,100 genes of the PM in this set are given. This analysis is represented by the first 
three columns in the table. In addition, this table gives results that switch the roles of the 
PM and CM. More specifically, the top 200 genes of the PM are selected as the base set 
and the number and percentage of the top 10, 20, . . ., 100 genes of the CM in this set are 
determined. This analysis is represented by the last three columns in Table 2. With the 
CM as the base set, the results range from 70% of the top 10 genes to 22% of the top 100 
genes of the PM being in set of the top 200 genes of the CM. Similarly, with the PM as 
the base set, the results range from 50% of the top 10 genes to 22% of the top 100 genes 
of the CM being in the set of the top 200 genes of the PM. Thus, while there is agreement 
between the two approaches, the lack of agreement warrants further investigation on the 
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best choice of method based on the criteria of highest SP and lowest FDR. Our last study 
is a Monte Carlo simulation data study to compare these two approaches under these 
criteria.  
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Figure 4. EA1 Score plot (a) and gene signature plot (b) for the skeletal muscle 
growth in mice study   
The score plot shows excellent grouping for the mutant mice (A) and the wild-type mice 
(B) assays. For the signature plot on the right, the rank decreases as the number increases. 
The top ranking genes seen on the left in this plot show excellent ranking as evidenced by 
the vertical line and clear separation of the most highly ranked genes. 
 
Table 2: Top ranked genes of one method in the top 200 genes of the other method 
in skeletal muscle growth in mice study   
This table shows how many of the top genes for one method are in the top 200 genes of 
the other method with x = # of top PM genes and y = # of top CM genes. For example, 
the result for x = 30 means that 10 (33%) of the top 30 genes of the PM where in the top 
200 genes of the CM. 
x 
x in top 200  
CM genes 
%x in Top 200  
CM genes 
Y 
y in top 200  
PM genes 
%y in Top 200 
 PM genes 
10 7 70 10 5 50 
20 9 45 20 7 35 
30 10 33 30 7 23 
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40 10 25 40 11 28 
50 11 22 50 15 30 
60 17 28 60 17 28 
70 19 27 70 17 24 
80 20 25 80 19 24 
90 20 22 90 20 22 
100 21 21 100 21 21 
 
Simulation Study 
As stated above, the purpose of the simulated data study is to evaluate and 
compare the PM and CM to identify genes with significant differential effects.  We 
simulated several data sets based on the statistical properties of the data matrix from the 
second study. Each data matrix contained 40,000 genes with 10 assays of five samples in 
each group. The distribution for the simulated data can be described as follows: 
  x N i jij
indep
x xj i~ , , , 
2                                           (24) 
such that 


 

otherwise
ji
jx ,3.5
5...,,1;200...,,1;0,3.5 
                 (25) 
                          
Thus, 200 of the genes for each of the assays in Group A had the largest mean and were 
significantly different than all the other genes that had a mean of 5.3. The study will 
evaluate the ability of the CM and PM to identify these 200 genes when the variance for 
all the data in the data matrix is the same (Part 1) and when the variance differ from gene 
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to gene (Part 2). Each result in the simulation study is an average of five trials. All the 
results for PM will be based on eigengene (EG) principal components (PCs). 
Simulation Study -- Part 1 
 In the first simulation study we evaluated the techniques under different levels of 
 xi
2  with δ = 1.  There were seven levels of these values that ranged from 0.04 to 1.0. 
Thus, the range of the ratio of xi to the differential effect (δ) was also 0.2 to 1.0. The 
PCA results for one trial of the PM at the lowest level of  xi  are given in Fig. 5. As 
shown, the loading plot indicates excellent separation of Group A and Group B indicating 
that PCA was able to pick up a difference of δ = 1 quite well for 200 of the 40,000 genes 
using the Tdiff
EG
i1
 test statistic. The signature plot reveals a distinct signature for these genes 
as evidenced by the large gap. For this case the percents of the 200 significantly different 
genes (SDG) ranked in the top 200 by Tdiff
EG
i1
, Tscaled
EG
i1
and Tpooledi ,were 100.0%, 99.9% and 
90.9%, respectively. These percentages for all the cases for this part of the simulation 
study for these three test statistics are given in Fig. 6. In addition, this figure gives results 
for percentages of the SDG in the top 300 and top 400 for these test statistics. As shown, 
Tdiff
EG  has the best performance, followed closely by Tscaled
EG
at the extremes and poorly by 
CM statistic Tpooled .  Thus, when the variability of the assays is similar, Tdiff
EG appears to be 
the best choice for identifying the most significant genes.  
Simulation Study -- Part 2 
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In the second simulation study we evaluated the techniques by varying levels of 
 xi
2 for each gene and two levels of δ: 1 and 3. More specifically, the distribution for  xi
was log normal with mean 0.37 and variance 0.37
2
. Thus, for each data table a  xi was 
randomly generated for each gene i, i = 1, ..., m, and then ten simulated expression values, 
one for each assay, were generated according to Eqs. 24 and 25 for the given level of δ. 
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Figure 5: Loading1 plot when δ = 1 and σ = 0.20 (a) and its sharp gene signature (b) 
Figure a shows a nice clean separation of Group A from Group B. Figure b shows the 
nice assay-specific gene signature plotted against their rank. 
 
   
 
 
 
 
                                       
 xi                                                                 
 xi  
Figure 6.  The % of the 200 significantly different genes (SDG) in the top lists for the 
three statistics in Simulation Study Part 1  
These results for Tdiff
EG and Tpooled are on the left and the ones for Tdiff
EG and Tscaled
EG
 are on the 
right. 
34 
 
 Identification results for this part of the study are given in Fig. 7 as the percent of 
the SDG that are in the top 200 and top 400 ranks determined by the three test statistics. 
The best performing method this time is Tscaled
EG , followed by Tpooled , and then by Tdiff
EG . At δ 
= 3, all three methods are close but spread out at δ = 1. While the spread at δ = 1 for 
Tscaled
EG
 and Tpooled is significant, the spread for Tpooled   and Tdiff
EG  is quite large. Thus, Tdiff
EG
does not appear to be the best choice when δ is small and there is significant variation 
between the genes across the assays. Since Tscaled
EG
 consistently did the best, when the gene 
variation is significant across the assays, it is our recommendation. 
 Our final analysis in this study evaluated performance in signature determination. 
The CM is the Q-method developed by Storey and Tibshirani (2003) that uses the p-
values of the pooled t-test (i.e., Tpooled) and cuts the list off at a maximum Q-value, 
commonly 0.05, the value used in this analysis. The PM is the Inflection Method (IM) 
that is described in Rollins et al. (2006) that cuts the list off at the greatest change in the 
signature plot of the ranked genes. The results are from Part 1 of the simulation study 
with a constant xi for all the genes in a data table. 
 The results of this analysis are given in Fig. 8. The plot gives the signature size 
(SS) (i.e., the number of genes in the signature) and the SDG against xi .Statistical 
Power is seen by the height of the SDG curve. As typical, SP, as indicated by this line, 
decreases as  xi increases. Hence, the PM signature performance is seen to be 
significantly better than the CM in terms of SP. An indication of the false discovery rate 
(FDR) of the methods can be compared by the separation of their two lines in Fig. 8. 
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These lines for the PM are very close except at the highest levels of  xi .This indicates 
that the number of insignificant genes in the signatures of the PM is quite small and 
hence, has a small FDR. The FDR of the CM appears to be much higher for low values 
 xi  and the SS drops to zero relatively quite fast so that performance at low  xi  is not too 
meaningful since there are very few genes in the signature. Thus, the IM with the test 
statistics of the PM for determining signature cutoffs appears to have merit as a viable 
approach.  
                               
 
 
 
 
 
Figure 7. The % of SDG in the top 200 (left) and in the top 400 (right) 
The plot shows percent of the 200 significantly different genes (SDG) that are in the top 
200 and 400 lists at two different values of δ for the three test statistics in Part 2 of the 
simulation study. 
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Figure 8. Signature Size (SS) performance for the CM and PM. 
The plot gives the signature sizes (i.e., number of genes the method determines as being 
significant) and the number of the 200 significantly different genes (SDG) in the 
signatures for the CM and PM. Higher statistical power (SP) is observed by the higher 
height of the SDG plot and the higher false discovery rate (FDR) is observed by the 
greater separation of the lines of the same color. 
 
V. CONCLUSION 
This work proposed a new principal component analysis (PCA) method for 
analyzing large dimensional data set such as gene expressions data set. The strength of 
the proposed method (PM) comes from its data driven nature. PCA is first used to verify 
the existence of the assay grouping of interests. From the principal components (PCs) that 
provide this verification, the contribution of each gene providing the greatest differential 
expressions based on linear combination from the PCs are ranked. Thus, a PM signature 
is not just a difference of expression levels for genes but differences in a direction 
verified to have the characteristics of interests. This approach distinguishes PM for 
methods that do not form groups on the basis of data analysis and develop signatures 
from the differences between two groups in the original data space.  
Following Rollins et al. (2006), the PM develops test statistics treating the assays 
as variables (eigengene, EG) and the genes as variables (eigenassay, EA). These test 
statistics are linear combinations of these variables (i.e., pseudo variables) as determined 
from the elements of the eigenvectors. One test statistic, called Tdiff is the difference of 
the average expression levels between two groups of pseudo variables. The other test 
statistics, called Tscaled, is Tdiff divided by the estimated pooled standard deviation. We 
compared the performance of these two test statistics with the common and popular 
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Student’s t-statistic, Tpooled that we called the current method (CM). Two real data studies 
provided evidence in support of the PM as a viable technique. A simulation study 
provided the strongest supportive evidence for the use of Tdiff when the gene variability is 
fairly uniform throughout a data table and for Tscaled when the variability is not fairly 
uniform. Finally, with the PM test statistics, the inflection method (IM) introduced by 
Rollins et al. (2006), indicated strong promise in determining signature cutoffs in terms 
of statistical power (SP) and false discovery rate (FDR) as compared to CM. 
We are applying the PM in a variety of applications involving biological as well 
as physical phenomenon, with promising results. These applications include: 1. Nitric 
Oxide- and S-nitrosoglutathione- responsive genes in E-coli; 2. analysis of DNA 
microarray data for juvenile small round blue cell tumors; 3. analysis of metabolite data 
from corn tissues (silk, pollen, coleoptile, and seedlings) for differential expression levels 
between the wild type and genetic mutations; 4. analysis of spectroscopy data for super 
alloys; and 5. the enhancement of nondestructive tests for ceramic armor in the resistance 
of ballistic penetration. Thus, the PM has potential application in a variety of situations 
where differential analysis is needed on large data tables with a relatively small number 
of different conditions or assays. It appears to have promise for these applications for 
high SP and low FDR as compared to other currently available methods. 
VI. ABBREVIATION 
FG, functional genomics; PCA, Principal Component Analysis; PC, Principal Component; 
EG, Eigengene; EA, Eigenassay; l, loading; S, score; PM, proposed method; CM, current 
method; Tdiff, difference of the average expression levels between two groups of pseudo 
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variables; Tscaled, scaled statistics by dividing Tdiff by its estimated pooled standard 
deviation; Tpooled, Student’s t-statistics; gi, gene contribution for i
th
 gene; δ, differential 
effect; SS, signature size; SDG, statistically different genes; SP, statistical power; FDR, 
false discovery rate; IM, inflection method  
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CHAPTER 4: DETERMINATION OF NITRIC OXIDE- AND S-
NITROSOGLUTHATHIONE- RESPONSIVE GENES IN 
ESCHERICHIA COLI USING DIFFERENTIAL PRINCIPAL 
COMPONENT ANALYSIS 
A paper to be submitted to BMC Bioinformatics 
 
AiLing Teh, Laura R. Jarboe, and Derrick K. Rollins, Sr. 
ABSTRACT 
Background: Escherichia coli(E. coli) resides inside the human body and during the 
course of infection is exposed to reactive nitrogen species (RNS) such as nitric oxide 
(NO) and S-nitrosoglutathione (GSNO). NO plays an important role in the mammalian 
immune system and regulation of blood flow. GSNO sometimes serves as a donor of NO, 
but its thiol chemistry also has effects distinct from NO. This work applies the recently 
developed Principal Component Analysis (PCA) technique of Rollins et al. (in review) in 
determining NO and GSNO response genes in an E. coli network. PCA is a powerful data 
mining method that is able to analyze and extract critical information from large 
microarray data sets even though the number of genes is much greater than the number of 
experimental runs.  
Result: The application of Rollins et al. technique identified a signature of NO-specific 
and GSNO- specific genes, containing those that were previously identified by Hyduke 
et. al. (2007) and Jarboe et. al. (2008) as well as new genes which may affect NO and 
GSNO activity. Three genes not previously identified as affecting NO and GSNO 
response were selected for experimental analysis to evaluate the identification ability of 
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the method. With control groups showing no significance, these genes were found to be 
significant at the 0.002 test level.   
Conclusions: Although the three chosen genes investigated in this work were not ranked 
very high in the list identified from the PCA method, the results support the ability of the 
method to successfully identified genes that affect NO and GSNO activity. Thus, the 
method appears to be robust and we recommend its use in new gene discovery 
applications using gene expression data. 
I. INTRODUCTION 
E. coli is one of the bacterial species that resides in the human digestive tract, but it is 
also the causative agent of diseases such as cystitis and pyelonephritis. Studies showed 
that during the course of infection, E. coli was affected by reactive nitrogen species (RNS) 
such as NO and GSNO [1- 3]. Moreover, NO is found to play an important role of 
fighting the infection inside the human body.  Network Component Analysis (NCA), a 
method based on known regulatory networks, was previously used to identify the 
molecular targets and response network to NO and GSNO [1-2]. The purpose of this 
work is to evaluate the ability of a new Principal Component Analysis (PCA) technique 
developed by Rollins et al (2010), to identify new genes that show effect on a chemical 
activity. More specifically, the identification ability of this method was evaluated in this 
work using NO and GSNO response networks.   
PCA has been widely used by practitioners to analyze microarray data set [5-8]. 
Two common strengths are its ability to reduce dimensionality and to create data driven 
methods by exploiting its ability to find natural relationships among correlated variables. 
The latter strength is the one we exploit in this work. Rollins et al. (2006) developed a 
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technique that uses gene contribution from biologically related groups identified by PCA 
to obtain ranked gene lists. Rollins et al. (2010) extended this technique to obtain ranked 
gene lists that use differential gene contribution between different biologically related 
groups identified by PCA. Rollins et al. (2010) evaluated this technique by comparing it 
to a previously identified list in a real data study and a known list in a simulated data 
study. In contrast, the work in this article evaluates the ability of this technique to identify 
new genes that affect a specific type of biological response and then to evaluate the 
accuracy of the identification results by experimentation. This study uses the responses to 
NO- and GSNO in E. coli as the biological system. It applies the PCA technique to 
identify ranked order list of genes and then select three genes from the lists for 
experimental validation of their responsive ability.     
II. METHODS 
The data matrix for this work has m = 4166 rows representing 4166 genes and n = 
4 columns or assays (i.e., experimental conditions). The cells in this matrix are given as 
xij which is the expression level of the ith gene for the jth assay. This microarray data 
matrix is from [1-2] and it gives the 5-minute response of E. coli strain BW25113 to four 
chemical treatments: the RNOS nitric oxide (NO, j = 1), and S-nitrosoglutathione (GSNO, 
j = 2), potassium cyanide (KCN, j = 3) and serine hydroxamate (SeOH, j = 4).  Potassium 
cyanide is known to cause respiration inhibition, one of the known effects of NO [4].  
Serine hydroxamate induces amino acid starvation [10], which was concluded to be an 
effect of both NO and GSNO treatment (Hyduke, Jarboe). KCN and SeOH are included 
to eliminate some of the indirect effects from NO and GSNO.  
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The PCA technique used in this work can be understood and appreciated by 
considering the following case. Suppose one is interested in finding a ranked order list of 
genes that express most differently for NO response versus the other three responses. One 
way of expressing this difference mathematically is: 
g x
x x x
i mi i
i i i 
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where gi gives the differential expression of gene i according to Eq. 1.  However, one 
problem with Eq. 1 is that it was written without evidence of the relationship it expresses. 
Thus, without evidence one cannot truly have confidence in its use to rank genes. 
Another problem is that it was not developed based on supporting empirical or much 
theoretical support and is therefore, likely far from optimal for ranking the genes.  
The PCA method of Rollins et al. (2010) does not suffer from these limitations. It 
treats either the assays or genes as variables and obtains Eigenvalues (called 
“Eigengenes,” EG treating assay as variables or “Eigenassays,” EA treating genes as the 
variables) that are used to validate the existence of the biological relationships of interests. 
It then uses this information to establish the mathematical expression to calculate the 
contribution of each gene to this relationship. More specifically, for this case, as 
described in Rollins et al. (2010), an EG analysis would plot the four (4) loadings for 
each principal component against the assay numbers. Similarly, an EA analysis would 
plot the product of the vector of the loadings for each principal component (PC) by each 
of the four genes vectors (producing four scores) against the assay numbers. The plots 
that are acceptable for this case would separate the loading for Assay 1 in the EG analysis 
from the loading for the other assays or the score for Assay 1 in the EA from the scores 
for the other assays. The EG or EA corresponding to plots that give the most distinct 
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separation would be used to determine the corresponding gene contribution equations as 
follow for EG and EA, respectively: 
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where in Eq. 2,  j is the jth loading or weight for this EG vector, j = 1, . . ., 4; and  
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While,  i in Eq. 3 is the ith loading for this EA vector. Note that in Eq. 2, each zij for gene 
i has a different loading that does not change from gene to gene and that in Eq. 3, each xij 
for gene i has the same loading that changes from gene to gene. Thus, by using loadings 
associated with PCs that distinguishes NO response from the other three, Eqs. 2 and 3 
will be more affective in ranking genes for NO responsiveness.  This same process can be 
applied for other responses of interests as long as the PCs can be found that reflect the 
behavior of interest. Next the procedures are presented to obtain the ordered lists from 
application of  Eqs. 2 and 3.  
Eigengene Procedure 
As stated above, the PCA technique has two ways of creating ranked order list of 
genes. In the context of the application of this work, we first describe the Eigengene (EG) 
procedure and then the Eigenassay(EA) procedure. For the EG procedure, the assays are 
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treated as the variables. The first step is to standardize the data matrix as described in 
Rollins et al. (2006). Next, using an appropriate software package the four loading and 
four score vectors are obtained from the standardized data matrix. The four elements of 
each loading vector are plotted against the four assay number creating four loading 
scatter plots. The loading plot showing sufficient and the greatest separation of Assay 1 
from the other assays is selected for the NO response. Similarly,  the plot showing 
sufficient and the greatest separation of Assay 2 from the other assays is selected for the 
GSNO response. Using the selected loading vectors, the contributions for each assay 
group are obtained using equations similar to Eq. 2 with the appropriate modifications 
based on the scattered plot for both NO and GSNO. Note that, as described in Rollins et 
al. (2006) the standardized values, defined as zij, are used in the contribution equations. 
The values of gEGi are then used to rank their associated genes. A line plot (called a 
signature plot in Rollins et al., 2006) of gEGi provides a visual representation of the 
sharpness of the ranking.  
Eigenassay Procedure 
For the EA procedure the genes are treated as the variables. This is done by taking 
the transpose of data matrix which is  an n x m matrix. Since the genes are spread along 
the columns it might not be possible to display this matrix in a spread sheet. In addition, 
because of the large number of variables, m, not all software packages will be able to do 
PCA on this matrix. We have found R [11-12], a free open statistical software package, to 
be quite effective for obtaining the PCs for the EA procedure. This software has several 
different ready packages that are written by professional which will help to obtain the 
loading and score vectors once the data is read into the workspace. The four elements of 
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each score vector are plotted against the four assay number creating four loading scatter  
plots. The plot showing sufficient and the greatest separation of Assay 1 from the other 
assays is selected for the NO response. Similarly, the plot showing sufficient and the 
greatest separation of Assay 2 from the other assays is selected for the GSNO response. 
Using the selected loading vectors, the contributions are obtained using equations similar 
to Eq. 3 with the appropriate modifications based on the scattered plot for both NO and 
GSNO. The values of gEAi are then used to rank their associated genes. A line (signature) 
plot of gEAi provides a visual representation of the sharpness of the ranking.  
III. RESULTS AND DISCUSSION 
As discussed on the previous section, we generated four loading plots using the EG 
procedure and four score plots using the EA procedure. The loading plots for Loading 
Vectors 2 (L2) and 4 (L4) are shown in Fig. 1. As shown, the plot for L2 indicates 
separation of GSNO and the one for L4 indicates separation for NO. Thus, L2 and L4 
were selected to create the ranked list of genes for GSNO and NO responses, respectively. 
The EG contribution equations for GSNO and NO are given below by Eqs. 5 and 6, 
respectively. 
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where  ij is the ith loading for the jth EG vector. Similarly, under the EA procedure, 
based on the score plots S1 and S3 in Fig. 2, we selected EA1 and EA3, to create the 
ranked list of genes for GSNO and NO, respectively where sij is the ith score for the jth 
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EA score vector.  The EA contribution equations for GSNO and NO are given below by 
Eqs. 7 and 8, respectively. 
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where  ij is the ith loading for the jth EA vector.  
 Figure 3 provides the EG signature plots for Eqs. 5 and 6. Similarly, Fig. 4 
provides EA signature plots for Eqs. 7 and 8. From the rank ordered differential gene 
contributions shown in the signature plots, differences plots below, the distinct gaps for 
the top genes are clearly revealed.   
 The top 25 genes that we identified to be important to direct NO target using EG 
and EA are showed in Tables 1 and 2 respectively. On the other hand, Tables 3 and 4 
show genes that identified to be important to direct GSNO target using EG method and 
EA method respectively. From these tables, the agreement is seen to be quite as most of 
the top genes identified from EG method matched with those that identified from EA 
method. Some of the top genes that we have identified have also been identified in other 
RNOS studies, as reviewed by (Jarboe et. al. NO: Biology and Pathobiology). In addition, 
our list includes a number of genes that, to our knowledge, have not been previously 
identified as important to the NO or GSNO response. Therefore, we selected three of 
these genes and investigate their ability to affect NO tolerance. 
 The eigengene and eigenassay methods both identified known NO-responsive 
genes hmp, norV, norW and ytfE as affecting NO response. Hmp and NorV both have 
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demonstrated NO-consuming activity and each of these four genes play an important role 
in NO defense [9].  Additionally, the NO-important genes include Fe-S cluster repair 
genes iscRSUA and many amino acid biosynthesis genes.  This is consistent with the 
previous report that NO damages the Fe-S center of many proteins, including branched-
chain amino acid biosynthesis protein IlvD, causing amino acid starvation (Hyduke et. 
al.).  For the GSNO response, the eigengene and eigenassay methods both identified 
many genes related to methionine and cysteine biosynthesis.  This is consistent with 
reports that GSNO depletes the levels of cysteine and the methionine precursor 
homocysteine (Jarboe et. al.).  Together, these findings validate the methodology 
presented here. However, this method also identified many genes that are outside the 
previously-reported NO and GSNO response models.  This includes several genes with 
minimal available functional or annotation data, such as yahN, ycbR, yciE, yeaR.   
 We have selected three genes that were not previously reported for NO responsive 
or GSNO responsive and worthwhile to experiment to verify the results. These three 
genes are ycbR, yfhA, and yahN. Note that, as seen from Tables 1 through 4, these genes 
are not ranked very high. The highest rank is for yahN -- 16 in Table 2 for NO. The rank 
for yfhA is 28 and is only ranked for the NO response in Table 2. While ycbR rank 
appears in three of the four lists, these ranks are 20, 34 and 45. Thus, these low ranks will 
strengthen the confidence in the method if these genes are found to have an effect. 
It was proposed that genes that are important to NO defense might have a positive 
effect on NO tolerance.  Wild-type E. coli shows a growth lag in response to treatment 
with 10 µM DEA/NO and this sensitivity is pronounced in the absence of the hmp gene 
(Hyduke et. al.).  Therefore, we increased the expression of the candidate genes, ycbR, 
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yfhA and yahN in BW25113 Δhmp and tested the growth response of the resulting strain 
to NO challenge. Figure 5 shows the growth response for the control (BW25113 Δhmp + 
blank TOPO vector) and the strains overexpressing yahN. The data shows a decrease in 
cell density relative to the control strain when yahN are overexpressed relative to the 
control vector.  Note that some other genes were also tested, but no significant difference 
was seen relative to the control. 
 To evaluate the significance of the linear change over time, we formally tested 
hypotheses for no slope versus the existence of a slope for both control and test cases. 
Note this is a simple t-test in classical simple linear regression. The results of analysis are 
given in Table 5 which indicates three runs for the ycbR and yfhA cases and one run for 
the yahN case. Three runs were performed for the yahN case but two are not reported due 
the experimental problems that caused these results to be inconclusive. Focusing on the 
average results, in agreement with PCA results, all three genes indicate significance 
effect as the slopes are indicated to be significant at the 0.002 test level with P-values of 
0.00122, 0.00119 and 0.00000196 for ycbR, yfhA and yahN, respectively. In contrast, 
none of the control cases have significant slopes for the averaged results with P-values of 
0.281, 0.372, and 1.00.  The negative slopes suggest that these genes may play an 
antagonistic role in NO and RNOS defense. However, further research will be needed to 
understand their affects on NO and RNOS defense which is beyond the scope of this 
work. Figure 5 is a plot of yahN case in Table 5 with fitted trend lines. As shown, the test 
run indicates a strong negative slope while the control run is quite flat. 
IV. CONCLUSION 
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This work evaluated the ability of the PCA technique of Rollins et al. (2010) to find 
genes that are differentially expressed between assay groups.  This technique is an 
extension of the Rollins et al. (2006) technique that focused strictly on ranking genes for 
a subset of assays with a common biological interpretation. This work provided the first 
test of this PCA technique in validation through experimentation on genes not known to 
have the identified effect. None of the selected genes had very high rank. However, since 
all three genes strongly indicated significance either on NO or GSNO response, the 
technique appears to have a degree of sensitivity which translates into power in statistical 
language. Power is the ability to find genes that are statistically significant. As power 
increases, the ability to find genes with weaker effect increases. In Rollins et al. (2010) 
the power of the technique was evaluated in a simulation study and the results compared 
well with a popular method. While much more experimental work is required to establish 
the strength of the technique evaluated in this work, these results are quite promising, and 
we, therefore, encourage its use.  
V. ABBREVIATIONS 
NO, nitric oxide; GSNO, S-nitrosoglutathione; KCN, potassium cyanide; SeOH, Serine 
hydroxamate; PCA, Principal Component Analysis; PM, proposed method; NCA, 
network component analysis; Tdiff, absolute different in gene contribution of two assay 
groups; E. coli, Escherichia coli; EG, Eigengene; EA, Eigenassay; principal components, 
PCs; RNS, reactive nitrogen species; DeaNO, diethylamine nitric oxide; IPTG, Isopropyl 
β-D-1-thiogalactopyranoside  
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VII. FIGURE LEGENDS 
Figure 1 - Loading plots generated for EG analysis 
Loading 2 is used to identify GSNO-response genes and Loading 4 is used to identify 
NO-response genes. Blue square circle represents one group and the black circles 
represent the other group.  
Figure 2 - Score plots generated for EA analysis 
S1 is used to identify GSNO-response gene and S3 is used to identify NO-response genes. 
Blue square circle represents one group and the black circles represent the other group.  
Figure 3 - Signature plots showing gene contribution ranking for NO (left) and 
GSNO (right) from EG method 
Signature plot for NO response is generated using Loading 4 while GSNO response is 
generated using Loading 2 respectively from EG method. 
Figure 4 - Signature plots showing gene contribution ranking for NO(left)  and 
GSNO(right) from EA method 
Signature plot for NO response is generated using Score 3 while GSNO response is 
generated using Score 1 respectively from EA method. 
Figure 5 – NO resistance for the yahN case in Table for the Test and Control run 
with10 µm DeaNO pumped and 0.01mm Isopropyl IPTG. 
Plot on the left show the response growth versus time for averages of control and ycbR 
while plot of the right corresponds to the averages of yfhA and control. From these plots, 
there are apparent changes in response growth as time increases. 
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VIII. TABLES 
Table 1 – Top 25 genes for NO direct target identified from Eigengene method.  
Ranking Gene Function 
1 hmp Flavohemoglobin; nitric oxide dioxygenase; dihydropteridine reductase; 
GSNO and nitrite reductase;  
2 norW NADH:flavoruberedoxin reductase 
3 norV Anaerobic nitric oxide reductase flavorubredoxin 
4 ytfE Iron-sulfur cluster repair protein; confers resistance to nitric oxide and 
hydrogen peroxide; di-iron center 
5 sdhC Oxidation of succinate, carries electrons from FADH to CoQ 
6 cydA Contains the heme b558 component of cytochrome bd-I 
7 carA Component of carbamoyl phosphate synthetase 
8 sdhA Catalytic subunits in the four subunit enzyme; contains the FAD cofactor 
9 yeaR Conserved protein yeaR 
10 cydB Bind the heme b595 component and iron-chlorin component of cytochrome 
bd-I 
11 sdhB Transfer redox centers, delivery electrons from the FAD cofactor in SdhA to 
the ubiquinone 
12 sdhD sdhABCD operon is negatively regulated by ryhB RNA as part of indirect 
positive regulation by Fur. 
13 iscR Transcriptional repressor for isc operon; contains Fe-S cluster; binds RNA in 
vitro 
14 b0725 Phantom gene, meaning that at a previous time it was thought to be a gene, 
but more recent analyses indicate it is not a gene 
15 ndk Catalyzes the reaction in which the terminal phosphate of a nucleoside-
triphosphate is transferred to a nucleoside-diphosphate  
16 oppA Component of oligopeptide ABC transporter; Oligopeptide transport, 
periplasmic oligopeptide binding protein 
17 cvpA Required for wild-type production of colicin V from an episomal gene 
18 yaiB Anti-adaptor protein required for stabilization of the alternative sigma factor 
19 sucA E1(0) component of the oxoglutarate dehydrogenase complex. 
20 pyrD Component of dihydroorotate oxidase 
21 yeeF Putative amino acid transporter of the APC superfamily 
22 rnpA Ribonucleaus P protein component 
23 glnL Sensor-histidine kinase; transmembrane protein composed of three domains 
24 rplM 50S ribosomal subunit protein L13 
25 fliR Integral membrane components of the flagellar export apparatus  
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 Table 2 – Top 25 genes for NO direct target identified from Eigenassay method.  
Genes bolded are genes selected to study in the experiment. 
Ranking Gene Function 
1 norW NADH:flavoruberedoxin reductase 
2 norV Anaerobic nitric oxide reductase flavorubredoxin 
3 hmp Flavohemoglobin; nitric oxide dioxygenase; dihydropteridine reductase; 
GSNO and nitrite reductase;  
4 ytfE Iron-sulfur cluster repair protein; confers resistance to nitric oxide and 
hydrogen peroxide; di-iron center 
5 yeaT Regulate the expression of yeaU, which encodes a D-malate 
dehydrogenase essential for growth on D-malate 
6 hscB Involved in iron-sulfur cluster assembly. HscB physically interacts with 
HscA and with IscU  
7 yfjL CP4-57 prophage; predicted protein; function unknown 
8 yoaG yoaG is thought to form an operon together with yeaR. Transcription of 
yoaG is induced in response to nitrate 
9 yeaR Conserved protein 
10 argC ArgC catalyzes the NADPH-dependent reduction of N-acetylglutamyl-
phosphate to yield N-acetyl-L-glutamate 5-semialdehyde 
11 hcp The hybrid cluster protein (HCP) exhibits hydroxylamine reductase 
activity, possibly functioning as a scavenger of toxic by-products of 
nitrogen metabolism 
12 iscU IscU is a scaffold protein for assembly and transfer of iron-sulfur 
clusters. 
13 nuoC NADH:ubiquinone oxidoreductase subunit C, complex I; NADH 
dehydrogenase I 
14 ilvC Ketol-acid reductoisomerase 
15 iscS Component of cysteine desulfurase 
16 yahN Predicted neutral amino acid efflux system 
17 fdx Ferredoxin, an iron-sulfur protein; involved in assembly of other Fe-S 
clusters 
18 hypF Hydrogenase maturation protein 
19 ilvB Component of acetohydroxybutanoate synthase I 
20 ycbR Putative periplasmic pilus chaperone, induced by AI-2 pheromone, 
function unknown 
21 iscX Protein with possible role in iron-sulfur cluster biogenesis 
22 puuD Component of y-glutamyl-y-aminobutyrate hydrolase 
23 argG Component of argininosuccinate synthase 
24 yciE Conserved protein 
25 ilvN Component of acetohydroxybutanoate synthase I 
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Table 3 - Top 25 genes for GSNO direct target identified from Eigengene method. 
Ranking Gene Function 
1 yedN_1 Hypothetical protein 
2 metR Positive regulatory gene for metE and metH; autogenous regulation 
3 metA Homoserine O-transsuccinylase 
4 yigM Predicted inner membrane protein 
5 carA Component of carbamoyl phosphate synthetase 
6 cspB Qin prophage; cold shock protein 
7 uspB Predicted universal stress (ethanol tolerance) protein B 
8 hmp Flavohemoglobin; nitric oxide dioxygenase; dihydropteridine reductase; 
GSNO and nitrite reductase;  
9 fliR Integral membrane components of the flagellar export apparatus  
10 ybdL Methionine aminotransferase, PLP-dependent 
11 metN L,D-methionine transporter, ATP-binding protein; methionine 
sulfoximine sensitivity 
12 yaiB Anti-adaptor protein that is required for stabilization of the alternative 
sigma factor 
13 rnpA Ribonucleaus P protein component 
14 dnaK Chaperone Hsp70; DNA biosynthesis; autoregulated heat shock proteins 
15 rpsA 30S ribosomal subunit protein S1 
16 mmuP S-methylmethionine permease, CP4-6 putative prophage remnan 
17 metF Component of 5,10-methylenetetrahydrofolate reductase 
18 glnA Adenylyl-[glutamine synthetase], GlnA 
19 mmuM S-methylmethionine:(seleno)homocysteine methyltransferase; CP4-6 
putative prophage remnant 
20 metB Cystathionine gamma-synthase; homotetrameric 
21 cysJ Sulfite reductase [NADPH] flavoprotein alpha-component; binds FMN 
and FAD 
22 rpsU 30S ribosomal subunit protein S21 
23 glnL Sensor-histidine kinase; transmembrane protein composed of three 
domains 
24 ytfE Iron-sulfur cluster repair protein; confers resistance to nitric oxide and 
hydrogen peroxide; di-iron center 
25 ybdH Predicted oxidoreductase 
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Table 4 - Top 25 genes for GSNO direct target identified from Eigenassay method. 
Ranking Gene Function 
1 yedN_1 Hypothetical protein 
2 metR Positive regulatory gene for metE and metH; autogenous regulation 
3 metF Component of 5,10-methylenetetrahydrofolate reductase 
4 yigM Predicted inner membrane protein 
5 metA Homoserine O-transsuccinylase 
6 ygcN Predicted oxidoreductase with FAD/NAD(P)-binding domain 
7 cysJ Sulfite reductase [NADPH] flavoprotein alpha-component; binds FMN 
and FAD 
8 cysH Component of 3'-phospho-adenylylsulfate reductase 
9 cysN Component of SULFATE-ADENYLYLTRANS-CPLX; sulfate 
adenylyltransferase 
10 mmuP S-methylmethionine permease, CP4-6 putative prophage remnan 
11 ybdL Methionine aminotransferase, PLP-dependent 
12 mmuM S-methylmethionine:(seleno)homocysteine methyltransferase; CP4-6 
putative prophage remnant 
13 cysD Component of Sulfate-Adenylyltrans-CPLX; sulfate adenylyltransferase 
14 sbp Component of sulfate ABC transporter 
15 yeeE Putative transport system permease protein 
16 metN L,D-methionine transporter, ATP-binding protein; methionine sulfoximine 
sensitivity 
17 metB Cystathionine gamma-synthase; homotetrameric 
18 uspB Predicted universal stress (ethanol tolerance) protein B 
19 yjdK Hypothetical protein; predicted protein 
20 cspB Qin prophage; cold shock protein 
21 cysI Sulfite reductase [NADPH] hemoprotein beta-component; has 4Fe-4S 
iron-sulfur center 
22 ybdH Predicted oxidoreductase 
23 ydcD Hypothetical protein 
24 thrA Component of aspartate kinase I 
25 dnaK Chaperone Hsp70; DNA biosynthesis; auto-regulated heat shock proteins 
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Table 5 – P-values for Test versus Control for evaluating the significant effect for 
three identified genes in Tables 1 and 2 
Run 
ycbR yfhA yahN 
Test Control Test Control Test Control 
1 3.48(10
-3
) 6.73(10
-1
) 8.66(10
-6
) 1.21(10
-1
) 1.96(10
-6
) 1.00(10
-1
)  
2 6.68(10
-6
) 7.87(10
-3
) 3.40(10
-4
) 9.18(10
-1
)   
 3 1.60(10
-4
) 1.65(10
-1
) 3.21(10
-3
) 7.70(10
-2
)     
Mean 1.22(10
-3
)*
 
2.81(10
-1
) 1.19(10
-3
)* 3.72(10
-1
) 1.96(10
-6
)* 1.00(10
-1
)  
*significant at the 0.002 level 
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Figure 3 
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Figure 5 
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CHAPTER 5. SUMMARY AND FUTURE WORK 
I. SUMMARY  
The differential PCA method described is a powerful method for analyzing large 
dimensionality data, t such as microarray data. This method is unique and effective for 
several reasons. First, it is able to effectively generate an assay specific gene signature 
that shows a distinct difference for assay groups. Second, it is able to control the FDR 
and also achieve high power at the same time when performing data analysis. This 
differential PCA method, which is also an extension of work from Rollins et. al.(2006),  
is proven to be highly effective through all the real data case studies as well as a 
simulation study. 
We have successfully applied this method to two E. coli data sets where one of them 
deals with the study of two different ethanol levels to the genes [2] and the second study 
identifies Nitric Oxide (NO) specific and S-nitrosoglutathione (GSNO) specific genes in 
E. coli [3 - 4]. This method also performed very well in a data set that involved the study 
of the effect of myostatin on mice [5].   
This approach is currently being tested on a large dimensionality data set that is not 
microarray experiment data. At the moment, it is showing  great success in the trial runs 
completed thus far. This indicates that the differential PCA method is not only applicable 
to microarray experiment data set but also to all other large dimensionality data sets that 
contain a wealth of information where differential analysis is needed. 
II. FUTURE WORK 
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Principal component analysis is proven to be a powerful statistical tool to analyze 
microarray data. The current approach uses different statistical software as well as 
mathematical procedures to perform the analysis. Since this method is performed using 
different statistical software and procedures, it would be valuable to combine all the 
individual steps into a single package. This methodology can be further extended by 
developing a user friendly and easy to operate software package incorporating all 
methods and steps taken to perform the data analysis.  
As verified, this is a powerful statistical method for analyzing large dimensionity 
microarray data. It may also be worthwhile to try applying this method to other large 
dimensionality data sets other than microarray data sets when the objective of the 
research is to identify subjects that express differentially between two or more different 
conditions. I believe this statistical approach is able to effectively extract important 
information as well as make a sound interpretation of the data.    
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